Return on investment (ROI), also called return on invested capital, is the profit a company earns for every dollar of long-term capital from both lenders and shareholders, shown as a percentage. It is net income divided by long-term debt plus shareholder equity, and the table shows both amounts. Because debt is included in the base, ROI does not rise just because a company replaces equity with borrowing, which sets it apart from ROE. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.
SELLAS Life Sciences Group, Inc. roi for the quarter ending 2018-12-31 was -527.55%, a change of -345.64% year-over-year.
SELLAS Life Sciences Group, Inc. roi for the quarter ending 2018-09-30 was -124.82%.
SELLAS Life Sciences Group, Inc. roi for the quarter ending 2018-06-30 was -515.43%.
SELLAS Life Sciences Group, Inc. roi for the quarter ending 2018-03-31 was -324.81%.
SELLAS Life Sciences Group, Inc. roi for fiscal 2018 was -527.55%, a change of -345.64% from fiscal 2017.
SELLAS Life Sciences Group, Inc. roi for fiscal 2017 was -181.91%.
SELLAS Life Sciences Group, Inc. roi for fiscal 2015 was 849.42%, a change of 929.94% from fiscal 2014.
SELLAS Life Sciences Group, Inc. roi for fiscal 2014 was -80.52%, a change of 405.46% from fiscal 2013.